636 results on '"Fiorentino David"'
Search Results
2. Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative
3. Xist ribonucleoproteins promote female sex-biased autoimmunity
4. Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis
5. Genomic signatures characterize leukocyte infiltration in myositis muscles
6. Autoantibodies and Cancer Association: the Case of Systemic Sclerosis and Dermatomyositis
7. Dermatomyositis
8. Myositis and Its Mimics: Guideline Updates, MRI Characteristics, and New Horizons
9. Update on Cutaneous Signs to Assist in the Diagnosis of Dermatomyositis
10. Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosis
11. International exchange on the clinical practice and research of rheumatic skin diseases: A report of the 5th International Conference of Cutaneous Lupus Erythematosus.
12. Novel therapeutic targets in dermatomyositis.
13. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank
14. Management Considerations: Refractory Skin Rash and Calcinosis
15. Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity.
16. Gastrointestinal Perforation in a Patient With Antinuclear Matrix Protein 2 Antibody–Positive Dermatomyositis
17. IL-10 INHIBITS CYTOKINE PRODUCTION BY ACTIVATED MACROPHAGES
18. Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review
19. Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus—An Ongoing Need for International Consensus and Collaborations
20. International consensus criteria for the diagnosis of Raynaud's phenomenon
21. The Type I Interferon Signature Reflects Multiple Phenotypic and Activity Measures in Dermatomyositis
22. Management Considerations: Refractory Skin Rash and Calcinosis
23. Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence
24. Cutaneous Lupus Erythematosus
25. Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey
26. Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis
27. Author Correction: Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis
28. ISID0475 - Mucocutaneous ulcers and skin of color are associated with increased disease severity in anti-NXP2 dermatomyositis patients
29. Faculty Opinions recommendation of Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies.
30. Telangiectasias
31. Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles.
32. Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis
33. Anti‐CCAR1 autoantibodies are specific for anti‐TIF1γ ‐positive dermatomyositis and decrease cancer risk relative to the general population
34. Cessation of Immunomodulatory Medication Use in Dermatomyositis: A Single‐Center Cohort Study
35. Referee report. For: Case Report: Anti-MDA-5 dermatomyositis in a resource-limited setting [version 1; peer review: 1 approved, 1 approved with reservations]
36. Dermatomyositis, Skin
37. Association of Anti‐CCAR1 Autoantibodies With Decreased Cancer Risk Relative to the General Population in Patients With Anti–Transcriptional Intermediary Factor 1γ–Positive Dermatomyositis.
38. Current concepts and advances in dermatomyositis: a dermatological perspective
39. XIST ribonucleoproteins promote female sex-biased autoimmunity
40. Faculty Opinions recommendation of Trial of intravenous immune globulin in dermatomyositis.
41. 158 - Clinical significance of autoantibodies in inflammatory muscle disease
42. Filling the prescription gap: the value of community support in psoriasis management.
43. Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
44. Evidence supports blind screening for internal malignancy in dermatomyositis: Data from 2 large US dermatology cohorts
45. Factors Associated With Clinical Remission of Skin Disease in Dermatomyositis
46. Cutaneous Lupus Erythematosus
47. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria—methodological aspects
48. Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies
49. Faculty Opinions recommendation of IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function.
50. Faculty Opinions recommendation of Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.